LRGILS-NH2
Purity: ≥95%
Biological Activity
LRGILS-NH2 is a reversed amino acid sequence control peptide for SLIGRL-NH2, a protease-activated receptor-2 (PAR2) agonist that facilitates gastrointestinal transit in vivo.Active Analog also available.
Technical Data
(Modifications: Ser-6 = C-terminal amide)
The technical data provided above is for guidance only.
For batch specific data refer to the Certificate of Analysis.
Tocris products are intended for laboratory research use only, unless stated otherwise.
Additional Information
Background References
-
HAT1 induces lung cancer cell apoptosis via up regulating Fas
N Han, L Shi, Q Guo, W Sun, Y Yu, L Yang, X Zhang, M Zhang
Oncotarget, 2017;8(52):89970-89977. -
Evidence that PAR-1 and PAR-2 mediate prostanoid-dependent contraction in isolated guinea-pig gallbladder.
Tognetto et al.
Br.J.Pharmacol., 2000;131:689 -
Protease-activated receptor-2 (PAR-2)-related peptides induce tear secretion in Rats: Involvement of PAR-2 and non-PAR-2 mechanisms.
Nishikawa et al.
J.Pharmacol.Exp.Ther., 2005;312:324 -
Initial support for the hypothesis that PAR2 is involved in the immune response to Nippostrongylus brasiliensis in mice.
Devlin et al.
Parasitol.Res., 2007;101:105
Product Datasheets
Reconstitution Calculator
Molarity Calculator
FAQs
No product specific FAQs exist for this product, however you may
View all Peptide FAQsReviews for LRGILS-NH2
There are currently no reviews for this product. Be the first to review LRGILS-NH2 and earn rewards!
Have you used LRGILS-NH2?
Submit a review and receive an Amazon gift card.
$25/€18/£15/$25CAN/¥75 Yuan/¥2500 Yen for a review with an image
$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image